All articles by  

  1. Janssen seeks approval for new applications of multiple myeloma drug

    Janssen Pharmaceutica has filed an application with the European Medicines Agency (EMA) for expanded indication of Darzalex (daratumumab) to treat…
    Read More…

    25 Mar
  2. Thermo Fisher to buy Brammer Bio for $1.7bn

    Thermo Fisher Scientific has signed a definitive agreement to acquire viral vector manufacturing company Brammer Bio for a cash consideration…
    Read More…

    25 Mar
  3. Study finds new drug combo could treat paediatric brain tumour

    A new study conducted by the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine has…
    Read More…

    25 Mar
  4. UK MHRA recalls more batches of sartan medication

    The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has recalled three batches of Losartan tablets amid fears of contamination…
    Read More…

    22 Mar
  5. FDA approves Jazz Pharma’s sleep disorder drug Sunosi

    The US Food and Drug Administration (FDA) has approved Ireland-based Jazz Pharmaceuticals’ Sunosi (solriamfetol) drug to treat adults suffering from…
    Read More…

    22 Mar
  6. Takeda and HemoShear to develop new liver disease drugs

    Takeda Pharmaceutical has expanded its exclusive drug discovery partnership with biotechnology firm HemoShear Therapeutics to discover and develop additional new…
    Read More…

    22 Mar
  7. Inhalable oxytocin a potential treatment for postpartum haemorrhage

    Inhalable oxytocin may be used in resource-limited states to manage postpartum haemorrhage, as the result of a research agreement between…
    Read More…

    21 Mar
  8. Pfizer and Vivet Therapeutics to collaborate on Wilson disease therapy

    Pharmaceutical giant Pfizer has partnered with French gene therapy company Vivet Theraputics to begin a joint project researching Wilson disease….
    Read More…

    21 Mar
  9. Merck extends research alliance with NGM Bio

    Merck has expanded the research phase of its strategic alliance with NGM Biopharmaceuticals until March 2022. The initial five year…
    Read More…

    21 Mar
  10. Sage’s postpartum depression drug Zulresso gets FDA approval

    Sage Therapeutics has secured the US Food and Drug Administration (FDA) approval for its Zulresso (brexanolone) injection to treat postpartum…
    Read More…

    20 Mar

Go Top